We are live on ! Find out more
AEON.WS

AEON Biopharma Inc
AEON.WS

Delisted

AEON.WS was delisted on the 26th of April, 2024.

Back to rankings

49 hedge funds and large institutions have $2.87M invested in AEON Biopharma Inc in 2023 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 7 increasing their positions, 2 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

250% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 2

6% less funds holding

Funds holding: 52 → 49 (-3)

20% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 10

49% less capital invested

Capital invested by funds: $5.62M → $2.87M (-$2.76M)

Holders
49
Holders Change
-3
Holders Change %
-5.77%
% of All Funds
0.78%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
7
Reduced
2
Closed
10
Calls
$352K
Puts
–
Net Calls
+$352K
Net Calls Change
-$662K

Top Buyers

Rank Fund Capital Flow
1
SCM
Shaolin Capital Management
Florida
+$17.3K
2
UOC
UBS O'Connor
Illinois
+$6.49K
3
PC
Periscope Capital
Ontario, Canada
+$4.76K
4
LIM
Longfellow Investment Management
Massachusetts
+$3.74K
5
SG
StoneX Group
New York
+$2.92K

Top Sellers

Rank Fund Capital Flow
1
HIM
HGC Investment Management
Ontario, Canada
-$4K
2
RA
Ramius Advisors
New York
-$3K
3
Citadel Advisors
Citadel Advisors
Florida
-$2.7K
4
FIG
Fortress Investment Group
New York
-$2.1K
5
GPCM
Granite Point Capital Management
Massachusetts
-$2K
Name Holding Trade Value Shares
Change 		Change in
Stake
SC
26
Sculptor Capital
New York
$4.3K – – –
LIM
27
Longfellow Investment Management
Massachusetts
$3.57K +$3.74K +64,891 New
DCM
28
Dupont Capital Management
Delaware
$3.28K – – –
SG
29
StoneX Group
New York
$2.78K +$2.92K +50,542 New
AA
30
AQR Arbitrage
Connecticut
$2.75K – – –
FCM
31
Farallon Capital Management
California
$2.75K – – –
RCM
32
Rivernorth Capital Management
Florida
$2.69K +$1.82K +31,536 +237%
CS
33
Clear Street
New York
$2.67K +$951 +16,489 +51%
Jane Street
34
Jane Street
New York
$2.25K +$2.36K +40,928 New
D.E. Shaw & Co
35
D.E. Shaw & Co
New York
$2K – – –
MCM
36
Moore Capital Management
New York
$2K – – –
FTUS
37
Flow Traders U.S.
New York
$2K +$699 +12,123 +44%
ACA
38
Arena Capital Advisors
California
$1.65K – – –
Walleye Capital
39
Walleye Capital
New York
$1.55K +$1.63K +28,249 New
PAMP
40
Polar Asset Management Partners
Ontario, Canada
$1.5K – – –
Nomura Holdings
41
Nomura Holdings
Japan
$1.49K – – –
CIM
42
Cowen Investment Management
New York
$1.38K – – –
EH
43
EMG Holdings
Connecticut
$1.38K – – –
SSA
44
Schonfeld Strategic Advisors
New York
$1.26K – – –
FSI
45
Flow State Investments
Illinois
$1.21K +$115 +2,000 +10%
HF
46
HRT Financial
New York
$1K +$1.1K +19,029 New
Walleye Trading
47
Walleye Trading
New York
$876 +$919 +15,932 New
AA
48
Ancora Advisors
Ohio
$307 – – –
RCM
49
Robinson Capital Management
Michigan
$77 – – –
HIM
50
HGC Investment Management
Ontario, Canada
– -$4K -83,333 Closed
1
2
3

AEON.WS Hedge Fund Activity: Q1 2023 in Review

49 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in AEON Biopharma Inc (AEON.WS) for Q1 2023, worth a combined $2.87M — down 49% from $5.62M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of AEON.WS and 8 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 7 added.

The largest buyer was Shaolin Capital Management, adding an estimated $17.3K. The largest seller was HGC Investment Management, exiting entirely with an estimated $4K sold.

  • 49 institutional investors held AEON Biopharma Inc (AEON.WS) as of Q1 2023, down from 52 in Q4 2022.
  • Funds reported $2.87M of AEON Biopharma Inc stock for Q1 2023, down 49% quarter-over-quarter.
  • 8 funds opened new AEON Biopharma Inc positions in Q1 2023 and 10 closed out, a net change of -2 holders.
  • The largest AEON Biopharma Inc buyer in Q1 2023 was Shaolin Capital Management, an estimated $17.3K added.
  • The largest AEON Biopharma Inc seller in Q1 2023 was HGC Investment Management, an estimated $4K sold.

Based on aggregated 13F filings for Q1 2023.